Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22835
Title: The Atrium and Embolic Stroke: Myopathy Not Atrial Fibrillation as the Requisite Determinant?
Austin Authors: Sajeev, Jithin K;Kalman, Jonathan M;Dewey, Helen;Cooke, Jennifer C;Teh, Andrew W 
Affiliation: Department of Neuorosciences, Eastern Health, Melbourne, Victoria, Australia
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia
University of Melbourne, Melbourne, Victoria, Australia
Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia
Monash University, Melbourne, Victoria, Australia
Department of Cardiology, Eastern Health, Melbourne, Victoria, Australia
Issue Date: Mar-2020
Publication information: JACC. Clinical electrophysiology 2020; 6(3): 251-261
Abstract: Atrial fibrillation (AF) is well-recognized in the pathophysiology of left atrial thrombogenesis and resultant cardioembolic stroke. Subclinical AF is believed to account for a significant proportion of embolic stroke. However, recent randomized control trials failed to demonstrate a significant benefit for oral anticoagulation, in an unselected population with embolic stroke of undetermined source. This has reinvigorated the focus on finding robust markers to identify patients at risk of cardioembolic stroke. Several nonfibrillatory atrial electrical markers, along with structural and biochemical abnormalities, have been associated with ischemic stroke, independently of AF. An increasingly complex relationship exists among vascular risk factors, atrial remodeling, and thrombogenesis. Identifying robust markers of an underlying atrial myopathy may allow for early identification of patients at risk for cardioembolic stroke. This review outlines the inconsistencies in the evidence for AF as the prerequisite for left atrial thrombogenesis and embolic stroke. It will highlight the current evidence and controversies for adverse atrial remodeling, independent from rhythm, as a plausible mechanism for left atrial thrombogenesis and ischemic stroke.
URI: http://ahro.austin.org.au/austinjspui/handle/1/22835
DOI: 10.1016/j.jacep.2019.12.013
PubMed URL: 32192674
Type: Journal Article
Subjects: ESUS
atrium
myopathy
Stroke
thrombogenesis
Appears in Collections:Journal articles

Show full item record

Page view(s)

2
checked on Nov 30, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.